Consolidated statements of income and comprehensive income/loss (-)
|
Year ended 31 December |
|
|
|---|---|---|---|
(thousands of €, except per share data) |
2019 |
2018 |
Notes |
Revenues |
844,985 |
288,836 |
|
Other income |
50,905 |
29,009 |
|
Total revenues and other income |
895,890 |
317,845 |
|
|
|
|
|
Research and development expenditure |
(427,320) |
(322,875) |
|
General and administrative expenses |
(73,701) |
(35,631) |
|
Sales and marketing expenses |
(24,577) |
(4,146) |
|
Total operating expenses |
(525,597) |
(362,652) |
|
|
|
|
|
Operating profit/loss (-) |
370,292 |
(44,807) |
|
|
|
|
|
Fair value re-measurement of share subscription agreement and warrants |
(181,644) |
– |
|
Other financial income |
21,482 |
18,335 |
|
Other financial expenses |
(60,071) |
(2,737) |
|
|
|
|
|
Profit/loss (-) before tax |
150,060 |
(29,209) |
|
|
|
|
|
Income taxes |
(214) |
(50) |
|
|
|
|
|
Net profit/loss (-) |
149,845 |
(29,259) |
|
Net profit/loss (-) attributable to: |
|
|
|
Owners of the parent |
149,845 |
(29,259) |
|
Basic income/loss (-) per share |
2.60 |
(0.56) |
|
Diluted income/loss (-) per share |
2.49 |
(0.56) |
|
The accompanying notes form an integral part of these financial statements.
|
Year ended 31 December |
|
|
|---|---|---|---|
(thousands of €) |
2019 |
2018 |
Notes |
Net profit/loss (-) |
149,845 |
(29,259) |
|
Items that will not be reclassified subsequently to profit or loss: |
|
|
|
Re-measurement of defined benefit obligation |
(4,107) |
(94) |
|
Items that may be reclassified subsequently to profit or loss: |
|
|
|
Translation differences, arisen from translating foreign activities |
415 |
197 |
|
Other comprehensive income/loss (-), net of income tax |
(3,692) |
103 |
|
|
|
|
|
Total comprehensive income/loss (-) attributable to: |
|
|
|
Owners of the parent |
146,154 |
(29,155) |
|
The accompanying notes form an integral part of these financial statements.